Amgen Aktie
| 287,81USD | 7,86USD | 2,81% |
WKN: 867900 / ISIN: US0311621009
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99,74 |
| Vanguard Group, Inc. (Subfiler) | 9,28 |
| The Vanguard Group, Inc. | 9,13 |
| SSgA Funds Management, Inc. | 5,50 |
| State Street Corp. | 5,46 |
| Vanguard Total Stock Market ETF | 3,17 |
| BlackRock Fund Advisors | 3,07 |
| PRIMECAP Management Co. | 2,65 |
| Vanguard 500 Index Fund | 2,62 |
| Geode Capital Management LLC | 2,26 |
| BlackRock Institutional Trust Co. NA | 2,21 |
| Charles Schwab Investment Management, Inc. | 1,96 |
| Invesco QQQ Trust | 1,94 |
| Vanguard PRIMECAP Fund | 1,67 |
| Capital Research & Management Co. (International Investors) | 1,62 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 23 400 | 24 300 | 24 200 | 25 200 | 26 700 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,99 | 1,04 | 1,07 | 1,04 | 1,05 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 18 440 | 21 144 | 19 385 | 22 186 | 30 332 |
| Summe Anlagevermögen | 41 267 | 41 804 | 41 780 | 42 935 | 66 822 |
| Summe Aktiva | 59 707 | 62 948 | 61 165 | 65 121 | 97 154 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 30 431 | 33 445 | 33 979 | 39 640 | 65 423 |
| Summe Fremdkapital | 50 034 | 53 539 | 54 465 | 61 460 | 90 922 |
| Summe Eigenkapital | 9 673 | 9 409 | 6 700 | 3 661 | 6 232 |
| Summe Passiva | 59 707 | 62 948 | 61 165 | 65 121 | 97 154 |
Adresse
| One Amgen Center Drive, 91320-1799 Thousand Oaks | |
| Telefon | +1 (805) 447-1000 |
| Fax | +1 (805) 447-1010 |
| Internet | http://www.amgen.com |
Management
|
Amy E. Miles
Independent Director |
|
Brian J. Druker
Independent Director |
|
Charles M. Holley
Independent Director |
|
Darryl Sleep
Chief Medical Officer & Senior VP-Global Medical |
|
David M. Reese
Chief Technology Officer & Executive VP |
|
Derek Miller
Chief Human Resources Officer |
|
Ellen Jamison Kullman
Independent Director |
|
Esteban Santos
Executive Vice President-Operations |
|
Greg C. Garland
Independent Director |
|
James E. Bradner
Chief Scientific Officer |
|
Jean-Charles Soria
SVP-Research and Development |
|
Jonathan P. Graham
Secretary, Executive VP & General Counsel |
|
Li Yang
Scientific Director |
|
Linda H. Louie
Chief Accounting Officer & Vice President-Finance |
|
Linda H. Louie
Vice President-Finance |
|
Lori A. Johnston
Executive Vice President |
|
Mark J. Taisey
Senior VP-Global Regulatory Affairs & Strategy |
|
Mary Earley Klotman
Director |
|
Matthew C. Busch
Chief Accounting Officer & Vice President-Finance |
|
Michael V. Drake
Independent Director |
|
Mike Zahigian
Chief Information Officer & Senior Vice President |
|
Murdo J. Gordon
EVP-Global Commercial Operations |
|
Nancy A. Grygiel
Chief Compliance Officer |
|
Omar Syed Ishrak
Independent Director |
|
Paul Burton
Chief Medical Officer |
|
Peter H. Griffith
Chief Financial Officer & Executive Vice President |
|
Rachna Khosla
Senior Vice President-Business Development |
|
Robert A. Bradway
Chairman, President & Chief Executive Officer |
|
Robert A. Eckert
Lead Independent Director |
|
Robert T. Fremeau
Scientific Director |
|
Susan Sweeney
Senior VP-Global Marketing, Access & Capabilities |
|
Tyler E. Jacks
Independent Director |
|
Victoria H. Blatter
Senior Vice President-Global Government Affairs |
|
Wanda M. Austin
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
